Sean Maduck's most recent trade in Corcept Therapeutics Inc was a trade of 25,000 Stock option (right to buy) done . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 25,000 | 116,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.27 per share. | 01 Jul 2026 | 25,000 | 34,755 (0%) | 0% | 8.3 | 206,750 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 89.31 per share. | 01 Jul 2026 | 11,175 | 9,755 (0%) | 0% | 89.3 | 998,033 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 87.33 per share. | 01 Jul 2026 | 11,024 | 23,731 (0%) | 0% | 87.3 | 962,780 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 88.51 per share. | 01 Jul 2026 | 2,801 | 20,930 (0%) | 0% | 88.5 | 247,924 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 25,000 | 141,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.27 per share. | 01 Jun 2026 | 25,000 | 33,977 (0%) | 0% | 8.3 | 206,750 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 70.11 per share. | 01 Jun 2026 | 21,069 | 12,908 (0%) | 0% | 70.1 | 1,477,080 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 70.75 per share. | 01 Jun 2026 | 3,931 | 8,977 (0%) | 0% | 70.7 | 278,103 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2026 | 615 | 10,207 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 70.44 per share. | 01 Jun 2026 | 615 | 9,592 (0%) | 0% | 70.4 | 43,321 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.44 per share. | 01 Jun 2026 | 452 | 9,755 (0%) | 0% | 70.4 | 31,839 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.27 per share. | 27 May 2026 | 75,000 | 83,977 (0%) | 0% | 8.3 | 620,250 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2026 | 75,000 | 166,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 65.37 per share. | 27 May 2026 | 54,575 | 29,402 (0%) | 0% | 65.4 | 3,567,628 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 66.16 per share. | 27 May 2026 | 20,425 | 8,977 (0%) | 0% | 66.2 | 1,351,316 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 35.97 per share. | 02 Mar 2026 | 454 | 8,633 (0%) | 0% | 36.0 | 16,330 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 454 | 9,087 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.97 per share. | 02 Mar 2026 | 110 | 8,977 (0%) | 0% | 36.0 | 3,957 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 140,000 | 140,000 | - | - | Stock Option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jan 2026 | 34,000 | 5,147 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Other type of transaction at price $ 0.00 per share. | 08 Jan 2026 | 34,000 | 34,000 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jan 2026 | 20,570 | 39,147 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Other type of transaction at price $ 0.00 per share. | 08 Jan 2026 | 20,570 | 20,570 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 20,000 | 241,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 79.52 per share. | 01 Dec 2025 | 20,000 | 7,904 (0%) | 0% | 79.5 | 1,590,490 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.27 per share. | 01 Dec 2025 | 20,000 | 27,904 (0%) | 0% | 8.3 | 165,400 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2025 | 205 | 8,314 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 79.78 per share. | 01 Dec 2025 | 205 | 8,109 (0%) | 0% | 79.8 | 16,355 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.78 per share. | 01 Dec 2025 | 135 | 8,179 (0%) | 0% | 79.8 | 10,770 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2025 | 20,000 | 261,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.27 per share. | 03 Nov 2025 | 20,000 | 27,904 (0%) | 0% | 8.3 | 165,400 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 73.99 per share. | 03 Nov 2025 | 20,000 | 7,904 (0%) | 0% | 74.0 | 1,479,816 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.27 per share. | 01 Oct 2025 | 18,014 | 27,904 (0%) | 0% | 8.3 | 148,976 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 18,014 | 281,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 85.06 per share. | 01 Oct 2025 | 16,394 | 10,551 (0%) | 0% | 85.1 | 1,394,411 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 85.58 per share. | 01 Oct 2025 | 2,647 | 7,904 (0%) | 0% | 85.6 | 226,519 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 01 Oct 2025 | 1,986 | 9,890 (0%) | 0% | 5.0 | 10,029 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 1,986 | 0 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 83.73 per share. | 01 Oct 2025 | 959 | 26,945 (0%) | 0% | 83.7 | 80,301 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 02 Sep 2025 | 20,000 | 27,681 (0%) | 0% | 5.1 | 101,000 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2025 | 20,000 | 1,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 70.38 per share. | 02 Sep 2025 | 15,070 | 12,611 (0%) | 0% | 70.4 | 1,060,607 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 70.84 per share. | 02 Sep 2025 | 4,930 | 7,681 (0%) | 0% | 70.8 | 349,221 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.38 per share. | 02 Sep 2025 | 233 | 7,904 (0%) | 0% | 71.4 | 16,632 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 71.38 per share. | 02 Sep 2025 | 228 | 7,909 (0%) | 0% | 71.4 | 16,275 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2025 | 228 | 8,137 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 17 Jul 2025 | 4,315 | 22,020 (0%) | 0% | 5.1 | 21,791 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2025 | 4,315 | 57,466 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 73.48 per share. | 17 Jul 2025 | 4,315 | 17,705 (0%) | 0% | 73.5 | 317,054 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2025 | 473 | 56,993 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 73.44 per share. | 17 Jul 2025 | 473 | 17,705 (0%) | 0% | 73.4 | 34,737 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 17 Jul 2025 | 473 | 18,178 (0%) | 0% | 5.1 | 2,389 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 01 Jul 2025 | 205 | 17,910 (0%) | 0% | 5.0 | 1,035 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 205 | 61,781 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 73.45 per share. | 01 Jul 2025 | 205 | 17,705 (0%) | 0% | 73.5 | 15,058 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Jun 2025 | 40,000 | 59,717 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Other type of transaction at price $ 0.00 per share. | 12 Jun 2025 | 40,000 | 40,000 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 12 Jun 2025 | 35,007 | 42,688 (0%) | 0% | 5.0 | 176,785 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 35,007 | 21,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 67.53 per share. | 12 Jun 2025 | 27,865 | 14,823 (0%) | 0% | 67.5 | 1,881,818 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Jun 2025 | 10,024 | 7,681 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Other type of transaction at price $ 0.00 per share. | 12 Jun 2025 | 10,024 | 99,717 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 68.52 per share. | 12 Jun 2025 | 5,428 | 9,395 (0%) | 0% | 68.5 | 371,952 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 69.70 per share. | 12 Jun 2025 | 1,714 | 7,681 (0%) | 0% | 69.7 | 119,467 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 5.05 per share. | 02 Jun 2025 | 20,000 | 37,705 (0%) | 0% | 5.1 | 101,000 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 20,000 | 61,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 79.89 per share. | 02 Jun 2025 | 6,246 | 19,516 (0%) | 0% | 79.9 | 498,967 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 78.87 per share. | 02 Jun 2025 | 6,191 | 25,762 (0%) | 0% | 78.9 | 488,311 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 77.91 per share. | 02 Jun 2025 | 5,752 | 31,953 (0%) | 0% | 77.9 | 448,139 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 80.77 per share. | 02 Jun 2025 | 1,811 | 17,705 (0%) | 0% | 80.8 | 146,269 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 888 | 17,705 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 71.68 per share. | 02 Jun 2025 | 888 | 16,817 (0%) | 0% | 71.7 | 63,652 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 01 May 2025 | 26,554 | 112,176 (0%) | 0% | 5.1 | 134,098 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 26,554 | 81,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 72.21 per share. | 01 May 2025 | 25,847 | 86,329 (0%) | 0% | 72.2 | 1,866,355 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 71.94 per share. | 01 May 2025 | 12,856 | 85,622 (0%) | 0% | 71.9 | 924,818 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 01 May 2025 | 12,856 | 98,478 (0%) | 0% | 5.1 | 64,923 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 12,856 | 108,540 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 72.98 per share. | 01 May 2025 | 707 | 85,622 (0%) | 0% | 73.0 | 51,596 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.27 per share. | 31 Mar 2025 | 100,000 | 185,622 (0%) | 0% | 8.3 | 827,000 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 100,000 | 300,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 100.26 per share. | 31 Mar 2025 | 79,277 | 106,345 (0%) | 0% | 100.3 | 7,947,995 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 101.43 per share. | 31 Mar 2025 | 15,133 | 91,212 (0%) | 0% | 101.4 | 1,534,937 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 102.16 per share. | 31 Mar 2025 | 5,590 | 85,622 (0%) | 0% | 102.2 | 571,078 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 590 | 121,396 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 114.55 per share. | 31 Mar 2025 | 590 | 85,622 (0%) | 0% | 114.5 | 67,584 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 31 Mar 2025 | 590 | 86,212 (0%) | 0% | 5.1 | 2,980 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 24 Mar 2025 | 1,697 | 87,319 (0%) | 0% | 5.1 | 8,570 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 60.58 per share. | 24 Mar 2025 | 1,697 | 85,622 (0%) | 0% | 60.6 | 102,804 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2025 | 1,697 | 121,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 140,000 | 140,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 60.69 per share. | 28 Feb 2025 | 18,303 | 85,622 (0%) | 0% | 60.7 | 1,110,818 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 18,303 | 123,683 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 28 Feb 2025 | 18,303 | 103,925 (0%) | 0% | 5.0 | 92,430 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 59.07 per share. | 28 Feb 2025 | 266 | 85,356 (0%) | 0% | 59.1 | 15,713 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 266 | 85,622 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.58 per share. | 28 Feb 2025 | 228 | 85,090 (0%) | 0% | 60.6 | 13,812 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 66.92 per share. | 03 Feb 2025 | 20,000 | 85,318 (0%) | 0% | 66.9 | 1,338,400 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 11,986 | 10,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.88 per share. | 03 Feb 2025 | 11,986 | 97,304 (0%) | 0% | 3.9 | 46,506 | Common Stock |